The association between apolipoprotein E (ApoE) polymorphism and stroke is still controversial. This study investigated the potential association between ApoE genotypes and stroke subtypes, and risk factors for ischaemic stroke in Greek patients hospitalized with their first-ever ischaemic stroke. One hundred patients (70 men and 30 women; mean age ± SD 60.7 ± 9.8 years) were included in the study. The control group comprised 96 age-and sex-matched healthy volunteers. Cerebral infarction was classified as atherothrombotic, cardio-embolic or lacunar small-vessel stroke. The three common ApoE alleles (E2, E3 and E4) were determined using the seminested polymerase chain reaction. No significant difference in the ApoE alleles was found between patients and controls. Similarly, there was no significant association between ApoE alleles and stroke subtypes, common risk factors for ischaemic stroke and neck vessel stenosis. Although the sample size was small, these results do not support a role for ApoE polymorphism in the pathogenesis of ischaemic stroke.
MiyataMSmithJD: Apolipoprotein E allelespecific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet1996; 14: 55–61.
2.
SmithJDMiyataMPoulinSENeveuxLMCraigWY: The relationship between apolipoprotein E and serum oxidation-related variables is apolipoprotein E phenotype dependent. Int J Clin Lab Res1998; 28: 116–121.
3.
SlooterAJBotsMLHavekesLMdel SolAICrutsMGrobbeeDE: Apolipoprotein E and carotid artery atherosclerosis. The Rotterdam Study. Stroke2001; 32: 1947–1952.
4.
CoudercRMahieuxFBailleulSFenelonGMaryRFermanianJ: Prevalence of apolipoprotein E phenotypes in ischaemic cerebrovascular disease. A case-control study. Stroke1993; 24: 661–664.
5.
Pedro-BotetJSentiMNoguesXRubies-PratJRoquerJD'OlhaberriagueL: Lipoprotein and apolipoprotein profile in men with ischaemic stroke. Role of lipoprotein (a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism. Stroke1992; 23: 1556–1562.
6.
MargaglioneMSeripaDGravinaCGrandoneEVecchioneGCappucciG: Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischaemic stroke: An Italian case-control study. Stroke1998; 29: 399–403.
7.
PengDQZhaoSPWangJL: Lipoprotein (a) and apolipoprotein E epsilon 4 as independent risk factors for ischaemic stroke. J Cardiovasc Risk1999; 6: 1–6.
8.
KesslerCSpitzerCStauskeDMendeSStadlmullerJWaltherR: The apolipoprotein E and beta-fibrinogen G/A-455 gene polymorphisms are associated with ischaemic stroke involving large-vessel disease. Arterioscler Thromb Vasc Biol1997; 17: 2880–2884.
9.
CoriaFRubioINunezESempereAPSantaEngarciaNBayonC: Apolipoprotein E variants in ischaemic stroke. Stroke1995; 26: 2375–2376.
10.
HachinskiVGraffagninoCBeaudryMBernierGBuckCDonnerA: Lipids and stroke: A paradox resolved. Arch Neurol1996; 53: 303–308.
11.
FerrucciLGuralnikJMPahorMHerrisTCortiMCHymanBT: Apolipoprotein E epsilon 2 allele and risk of stroke in the older population. Stroke1997; 28: 2410–2416.
12.
McCarronMODelongDAlbertsMJ: APOE genotype as a risk factor for ischemic cerebrovascular disease: A meta-analysis. Neurology1999; 53: 1308–1311.
13.
SlooterAJCrutsMHofmanAKoudstaalPJvan der KuipDde RidderMA: The impact of APOE on myocardial infarction, stroke, and dementia: The Rotterdam Study. Neurology2004; 62: 1196–1198.
14.
SudlowCGonzalezNA MartinezKimJClarkC: Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17,965 controls. Stroke2006; 37: 364–370.
15.
GordonDLBendixenBHAdamsHPClarkeWKappelleLJWoolsonRF: Interphysician agreement in the diagnosis of subtypes of acute ischaemic stroke: Implications for clinical trials. Neurology1993; 43: 1021–1027.
16.
Kolominsky-RabasPLWeberMGefellerONeundoerferBHeuschmannPU: Epidemiology of ischaemic stroke subtypes according to TOAST criteria. Incidence, recurrence and long-term survival in ischaemic stroke subtypes: A population-based study. Stroke2001; 32: 2735–2740.
17.
The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the Expect Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care1997; 20: 1183–1197.
18.
Joint National Committee: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. The JNC 7 report. JAMA2003; 289: 2560–2572.
19.
HixsonJEVernierDT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res1990; 31: 545–548.
20.
FlossmannESchulzUGRRothwellPM: Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke2004; 35: 212–227.
21.
DichgansMMarkusHS: Genetic association studies in stroke. Methodological issues and proposed criteria. Stroke2005; 36: 2027–2031.
22.
CattoAJMcCormackLJMansfieldMWCarterAMBamfordJMRobinsonP: Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand2000; 101: 399–404.
23.
KokuboYChowdhuryAHDateCYokoyamaTSobueHTanakaH: Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke2000; 31: 1299–1306.
24.
SzolnokiZSomogyvariFKondacsASzaboMFodorL: Evaluation of the interactions of common genetic mutations in stroke subtypes. J Neurol2002; 249: 1391–1397.
